These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6882463)

  • 1. Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
    Leube K; Keppler DO
    Biochem Pharmacol; 1983 Jun; 32(12):1865-9. PubMed ID: 6882463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
    Aoki T; Sebolt J; Weber G
    Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridine triphosphate deficiency, growth inhibition, and death in ascites hepatoma cells induced by a combination of pyrimidine biosynthesis inhibition with uridylate trapping.
    Keppler DO
    Cancer Res; 1977 Mar; 37(3):911-7. PubMed ID: 189918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
    Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
    Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
    Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
    Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uridylate trapping, induction of UTP deficiency, and stimulation of pyrimidine synthesis de novo by D-galactosone.
    Keppler DO; Schulz-Holstege C; Fauler J; Reiffen KA; Schneider F
    Biochem J; 1982 Jul; 206(1):139-46. PubMed ID: 7126188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
    Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glutamine analog acivicin as antipyrimidine. Studies on the interrelationship between pyrimidine and urea synthesis in liver.
    Pausch J; Rasenack J; Häussinger D; Holstege A; Gerok W
    Adv Enzyme Regul; 1985; 24():233-43. PubMed ID: 3835821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
    Kensler TW; Jayaram HN; Cooney DA
    Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical pharmacology of acivicin in rat hepatoma cells.
    Lui MS; Kizaki H; Weber G
    Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of antimetabolite action by uridylate trapping.
    Keppler D; Holstege A; Weckbecker G; Fauler J; Gasser T
    Adv Enzyme Regul; 1985; 24():417-27. PubMed ID: 3835824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic carbamoyl phosphate metabolism. Role of cytosolic and mitochondrial carbamoyl phosphate in de novo pyrimidine synthesis.
    Pausch J; Rasenack J; Häussinger D; Gerok W
    Eur J Biochem; 1985 Jul; 150(1):189-94. PubMed ID: 4018077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ammonium ions on hepatic de novo pyrimidine biosynthesis.
    Monks A; Chisena CA; Cysyk RL
    Arch Biochem Biophys; 1985 Jan; 236(1):1-10. PubMed ID: 2981502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of Crithidia fasciculata carbamoyl phosphate synthetase II by the antitumor drug acivicin.
    Aoki T; Oya H
    Mol Biochem Parasitol; 1987 Mar; 23(2):173-81. PubMed ID: 3574357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
    Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of pyrimidine biosynthesis in the perfused liver. Feedback inhibition of glutamine-dependent carbamoyl phosphate synthetase.
    Pausch J; Wilkening J; Nowack J; Decker K
    Eur J Biochem; 1975 May; 53(2):349-56. PubMed ID: 166840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.